Citations as recorded by:

1. Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence

NeuroToxicology, 2017, 61 p. 143

DOI: 10.1016/j.neuro.2017.03.006

Citations as recorded by: Cross Ref

2. Overexpression of Ubiquilin-1 Alleviates Alzheimer’s Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice

JAD, 2017, 59(2) p. 575

DOI: 10.3233/JAD-170173

Citations as recorded by: Cross Ref

3. Reduced body weight gain in ubiquilin‐1 transgenic mice is associated with increased expression of energy‐sensing proteins

Physiol Rep, 2017, 5

DOI: 10.14814/phy2.13260

Citations as recorded by: PMC

4. A Novel Method to Identify Differential Pathways in Hippocampus Alzheimer’s Disease

Med Sci Monit, 2017, 23 p. 2179

DOI: 10.12659/MSM.900929

Citations as recorded by: Cross Ref PMC

5. Rpn1 provides adjacent receptor sites for substrate binding and deubiquitination by the proteasome

Science, 2016, 351(6275) p. aad9421

DOI: 10.1126/science.aad9421

Citations as recorded by: Cross Ref PMC